Navigation Links
March of Dimes Awards $250,000 Prize to Scientist Who Discovered How to Reprogram Human Cells
Date:1/26/2010

, during the annual meeting of the Pediatric Academic Societies. Also on May 3, Dr. Yamanaka will deliver the Fifteenth Annual March of Dimes Prize Lectures at the Vancouver Convention Centre.

Dr. Yamanaka is the L.K. Whittier Foundation Investigator in Stem Cell Biology at the Gladstone Institute of Cardiovascular Disease and Professor of Anatomy at the University of California, San Francisco. He also is the director of the Center for iPS Cell Research and Application at the Institute for Integrated Cell-Material Sciences, and professor in the Department of Stem Cell Biology at the Institute for Frontier Medical Sciences, both at Kyoto University in Japan.

The March of Dimes Prize in Developmental Biology has been awarded annually since 1996 to investigators whose research has profoundly advanced the science that underlies the understanding of birth defects.  The March of Dimes Foundation created the Prize as a tribute to Dr. Jonas Salk, who received Foundation support for his work to create a polio vaccine.

The March of Dimes is the leading nonprofit organization for pregnancy and baby health.  With chapters nationwide and its premier event, March for Babies®, the March of Dimes works to improve the health of babies by preventing birth defects, premature birth and infant mortality.  For the latest resources and information, visit marchofdimes.com or nacersano.org.

SOURCE March of Dimes

RELATED LINKS
http://www.marchofdimes.com/
http://www.nacersano.org

'/>"/>

SOURCE March of Dimes
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. China Medical Technologies to Announce Unaudited Financial Results for the Fourth Fiscal Quarter and Fiscal Year ended March 31, 2009 and the First Fiscal Quarter ended June 30, 2009 on September 1, 2009
2. The Crohns & Colitis Foundation of America and Shire Launch Virtual IBD March on the Hill to Increase Funding for Digestive Disease Research
3. Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009
4. Bavarian Nordic Announces its Interim Report for the Period 1 January to 31 March 2009
5. The MedZilla Report: March 2009 Employment Outlook for Biotech/Pharma/Health
6. Yongye Biotechnology Announces Preliminary Results for its Fiscal Quarter Ended March 31, 2009
7. New Discoveries on a Fingertip Test for Screening Silent Heart Disease Promising Results of Recent Clinical Studies to be Presented during the 2009 American College of Cardiology Conference, March 29th - April 1st in Orlando
8. Cell Therapeutics, Inc. Special Meeting in Lieu of Annual Meeting of Shareholders Scheduled for Tuesday, March 24, 2009
9. Horizon Therapeutics Selected to Present at InsideVentures Debut Investor Conference March 25-26, Santa Barbara, California
10. PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009
11. Milestone Scientific to Report 2008 Year-End Results on Tuesday, March 17, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)...  Pfenex Inc. (NYSE MKT: PFNX) a clinical-stage ... therapeutics including high value and difficult to manufacture ... announced underwritten public offering of 6,750,000 shares of ... of $15.50 per share. This includes the exercise ... to purchase up to 750,000 additional shares of ...
(Date:4/30/2015)... Available in select spas in ... , Phytomer’s DOUCEUR INTEMPORELLE Restorative Shield Cream provides ... battling the weakening threat of inflammaging, aging directly ... with star ingredient GLYCOSEA, a complex of restructuring ... of soothing minerals and trace elements. GLYCOSEA works ...
(Date:4/29/2015)... BALTIMORE, Maryland, USA (PRWEB) April 29, 2015 ... photonics, optical sensing, and imaging on the East Coast, ... government program managers, researchers, applications developers, and industry suppliers ... sensing and imaging for multiple applications. , The event ... security, and commercial and scientific sensing and imaging -- ...
(Date:4/29/2015)... (PRWEB) April 29, 2015 The leading ... announce that its regenerative stem cell therapy has processed ... 2002, seeking to discover a successful treatment for horses ... In 2003 VetStem signed a worldwide exclusive license for ... and the first horse was treated in January 2004. ...
Breaking Biology Technology:Pfenex Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 2Phytomer introduces DOUCEUR INTEMPORELLE Restorative Shield Cream 2Phytomer introduces DOUCEUR INTEMPORELLE Restorative Shield Cream 3SPIE DSS provides venue for collaboration vital to research, applications advances 2SPIE DSS provides venue for collaboration vital to research, applications advances 3SPIE DSS provides venue for collaboration vital to research, applications advances 4VetStem Biopharma -Regenerative Cell Therapy has processed over 11,000 samples 2
... Dec. 29, 2010 Reportlinker.com announces that ... in its catalogue: Molecular Diagnostics Markets ... The technologies that constitute molecular ... situ hybridization (FISH), second-generation biochips and microfluidics, ...
... DIEGO, Dec. 28, 2010 Cardium Therapeutics (NYSE Amex: ... the Company,s Matrix Phase 2b clinical study has been ... and Regeneration and provided an update on plans ... dressing.   (Logo:   http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO ) ...
... 2010 An international team of researchers featuring Texas ... that gives a new spin to semiconductor nanoelectronics and ... developed an electrically controllable device whose functionality is based ... a 20-year scientific quest involving many international researchers and ...
Cached Biology Technology:Reportlinker Adds Molecular Diagnostics Markets 2Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans 2Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans 3Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans 4Texas A&M professor helps develop first high-temp spin-field-effect transistor 2Texas A&M professor helps develop first high-temp spin-field-effect transistor 3
(Date:4/20/2015)... , April 20, 2015 ...   Glenbeigh Records Management (GRM), Ireland,s ... with Dubai Islamic Bank. Having built up an impressive track ... now a leading player within the records management sector in ... expects to double is GCC staffbase and employ a further ...
(Date:4/13/2015)...  higi, a leading cloud-based consumer engagement platform that ... with their communities around health and wellness, announced today ... API.  ... and convenient vehicle to receive validated health information from ... The API will allow higi,s trusted partners, on a ...
(Date:4/2/2015)... 2015 In the current ... outperforms the strongest competitors, showing outstanding performance in ... system is capable of a throughput of 5.000.000 ... to be ten times faster than most competitors ...      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ) ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
... Biologists have identified plant enzymes that may help to ... to use water more efficiently. The finding could help ... gases. Plants take in the carbon dioxide they ... surface of leaves. But for each molecule of the ...
... by Yale University researchers has used nanosensors to measure ... Their findings, which appear December 13 in the advanced ... simplify the way physicians test for biomarkers of cancer ... Mark Reed, Yale,s Harold Hodgkinson Professor of Engineering & ...
... 2009Researchers at The Scripps Research Institute have solved a ... ancient family of enzymes can have two completely distinct ... for understanding other molecules in the family, the research ... for combating diseases including cancer and macular degeneration. ...
Cached Biology News:Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3
... Yersinia pestis This antibody is ... Immunogen: Purified F1 ... vaccine strain EV76. Specificity: ... capsular antigen. There is no cross-reactivity ...
Phospho-SEK1/MKK4 (Thr261) Antibody...
Rabbit polyclonal to Leucyl tRNA synthetase ( Abpromise for all tested applications). Antigen: L930-H1176 denatured human recombinant LRS. Entrez Gene ID: 3926 Swiss Protein ID: Q9P2J5...
Phospho-FADD (Ser194) Antibody (Human Specific)...
Biology Products: